As we wait to find out whether or not France decides to allow Sativex, a spray-on pain reliever made from Marijuana(!), I can’t help but ponder: What are the chances of America seeing this anytime soon?
Sativex is already on the market in Britain, Spain and a number of other European countries, so it just may become legally available for French patients.
Apparently, this spray-on treatment reduces muscle pain and is being used by patients suffering from things like multiple sclerosis, and cancer pains. Actually, from their site: “Sativex is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain and neuropathic pain of various origins.”
When can we get it?!
Here’s Some medical jargon from GWPharma, the maker of Sativex:
Sativex is the world’s first prescription medicine derived from the cannabis plant. The medicine is standardized by both composition and dose and is being developed for the treatment of conditions such as spasticity in multiple sclerosis, cancer pain, and neuropathic pain of various origins.
Sativex is administered as an oral spray which is absorbed by the patient’s mouth. Sativex contains active ingredients called ‘cannabinoids’, which are extracted from cannabis plants grown and processed under strictly controlled conditions. It is composed primarily of a 1:1 ratio of two cannabinoids-CBD (cannabidiol-a non-psychoactive cannabinoid) and THC (delta-9-tetrahydrocannabinol). The CBD:THC formulation is believed to enhance the therapeutic benefits of THC while modulating the unwanted psychotropic and other THC-related side effects, such as tachycardia. The spray delivery system keeps THC from entering the blood too rapidly and also minimizes the development of unwanted psychotropic effects.
GWPharma says their Sativex doesn’t induce a “high” like recreational marijuana, but has the ability to “dim down” the spasticity in patients.
Yet another reason why we need to see this marijuana legalization trend flow all the way to the white house so patients that require this type of pain medication can have access to it.